Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution

Critical Care Medicine

Volumn 24, Issue 12, 1996, Pages 1993-2000

  Przybelski, Robert J ^a   Daily, Elaine K ^a,c   Kisicki, James C ^b   Mattia Goldberg, Cynthia ^a   Bounds, Marilyn J ^a   Colburn, Wayne A ^b  

^a BAXTER HEALTHCARE CORPORATION   (United States)

^b Harris Laboratories Inc Lincolnshire   (United States)

^c NONE   (United States)

Author keywords

blood; critical illness; diaspirin cross linked hemoglobin; hemoglobin solution; oxygen; perfusion; pharmacodynamics; pharmacokinetics; pressor effect

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; DIASPIRIN CROSS LINKED HEMOGLOBIN SOLUTION; HEMOGLOBIN; LACTATE DEHYDROGENASE ISOENZYME; RINGER LACTATE SOLUTION; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD OXYGENATION; BLOOD PRESSURE; BODY TEMPERATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CRITICAL ILLNESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; HEMORRHAGIC SHOCK; HUMAN; HUMAN EXPERIMENT; LACTATE DEHYDROGENASE BLOOD LEVEL; LASER DOPPLER FLOWMETRY; MALE; PERFUSION; PHARMACODYNAMICS; PHASE 1 CLINICAL TRIAL; PRESSOR RESPONSE; PRIORITY JOURNAL; PULSE OXIMETRY; RANDOMIZED CONTROLLED TRIAL;

EID: 0029958436     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199612000-00011     Document Type: Article

References (28)

1. Estep TN, Bechtel MK, Miller TJ, et al: Virus inactivation in hemoglobin solutions by heat. In: Blood Substitutes. Chang TMS, Geyser RP (Eds). New York, Marcel Dekker, 1989, pp 129-134
2. Estep TN, Bechtel MK, Bush SL, et al: The purification of hemoglobin solutions by heating. Prog Clin Biol Res 1989; 319:325-336
3. Farmer MA, Ebeling T, Marshall W, et al: Validation of virus inactivation by heat treatment in the manufacture of diaspirin cross-linked hemoglobin. Biomaterials, Artificial Cells Immobilization Biotechnology 1992; 20:429-433
4. Hess JR, Wade CE, Winslow RM: Filtration-assisted exchange transfusion using a-aHb, an erythrocyte substitute. J Appl Physiol 1991; 70:1639-1644
5. Przybelski RJ, Malcolm DS, Burris DG, et al: Cross-linked hemoglobin solution as a resuscitative fluid after hemorrhage in the rat. J Lab Clin Med 1991; 117: 143-151
6. Powell CC, Schultz SC, Burris DG, et al: Resuscitation with diaspirin cross-linked hemoglobin (DCLHb™) restores subcutaneous oxygen tension as well as blood in rats. Surg Forum 1993; 44: 40-42
7. Hamilton I, Schultz SC, Cole F, et al: Characterization of hemodynamic response to intravenous diaspirin cross-linked hemoglobin solution in rats. Artificial Cells and Immobilization Biotechnology 1994; 22:91-107
8. Nanavaty M, Scandling DM, McKenzie J: Diaspirin cross-linked hemoglobin (DCLHb™): Characterization of blood pressure response in the swine. Program and Abstracts. Fifth International Symposium on Blood Substitutes, San Diego, CA, 1993
9. Powell CC, Schultz SC, Burris DG, et al: Subcutaneous oxygen tension: A useful adjunct in assessment of perfusion status. Crit Care Med 1995; 23: 867-873
10. Frankel HL, Nguyen HB, Shea-Donohue T, et al: Diaspirin cross-linked hemoglobin is efficacious in gut resuscitation as measured by a GI tract optode. J Trauma 1996, 40:231-241
11. Schultz SC, Hamilton IN, Malcolm DS: Use of base deficit to compare resuscitation with lactated Ringer's solution, haemaccel, whole blood, and diaspirin cross-linked hemoglobin following hemorrhage in rats. J Trauma 1993; 35: 619-626
12. Cohn SM, Farrell TJ: Diaspirin cross-linked hemoglobin resuscitation of hemorrhage: Comparison of a blood substitute with hypertonic saline and isotonic saline. J Trauma 1995; 39:210-217
13. Powell C, Schultz S, Malcolm D: Diaspirin cross-linked hemoglobin (DCLHb™): More effective than lactated Ringer's solution in restoring central venous oxygen saturation after hemorrhagic shock in rats. Biomaterials, Artificial Cells and Immobilization Biotechnololgy 1996; 24:25-29
14. McKenzie JE, Scandling DM, Ahle NW: Diaspirin cross-linked hemoglobin (DCLHb™): Improvement in regional blood flow following administration in hypovolemic shock in the swine. Program and Abstracts. Fifth International Symposium on Blood Substitutes, San Diego, CA, 1993
15. Gulati A, Sharma AC, Burhop KE: Effect of stroma-free hemoglobin and diaspirin cross-linked hemoglobin on the regional circulation and systemic hemodynamics. Life Sci 1994; 55:827-837
16. Sharma AC, Rebello S, Gulati A: Regional circulatory and systemic hemodynamic effects of diaspirin cross-linked hemoglobin in the rat. Artif Cells Blood Substit Immobil Biotechnol 1994; 22:593-602
17. Nolte D, Botzlar R, Hecht R, et al: Diaspirin cross-linked hemoglobin: Evaluation of effects on the microcirculation of striated muscle. Artif Cells Blood Substit Immobil Biotechnol 1994; 22:587-592
18. Chatterjee R, Welty EV, Walder RA, et al: Isolation and characterization of a new hemoglobin derivative cross-linked between the chains (lysine 99, - lysine 992). J Biol Chem 1986; 261:9929-9937
19. Directive 75/318/EEC: The Rules Governing Medicinal Products in the European Community, July 1991
20. 21 CFR: Code of Federal Regulations, April 1991
21. Savitsky JP, Doczi J, Black J, et al: A clinical safety trial of stroma-free hemoglobin. Clin Pharmacol Ther 1978; 23:73-80
22. Hess JR, Fadare SO, Tolentino LSL, et al: The intravascular persistence of cross-linked human hemoglobin. Prog Clin Biol Res 1989; 319:351-357
23. O'Rourke MR, Kelly R, Avolio A: The Arterial Pulse. Philadelphia, Lea & Febiger, 1992
24. Schultz SC, Grady B, Cole F, et al: A role for endothelin and nitric oxide in the presser response to diaspirin cross-linked hemoglobin. J Lab Clin Med 1993; 122:301-308
25. Sharma AC, Singh G, Gulati A: Role of nitric oxide mechanism in the cardiovascular effects of diaspirin cross-linked hemoglobin in anesthetized rats. Am J Physiol 1995; 269:H1379-H1388
26. Gulati A, Rebello S: Role of adrenergic mechanisms in the pressor effect of diaspirin cross-linked hemoglobin. J Lab Clin Med 1994; 124:125-133
27. Sharma AC, Gulati A: Yohimbine modulates diaspirin cross-linked hemoglobin-induced systemic hemodynamics and regional circulatory effects. Crit Care Med 1995; 23:874-884
28. Bilello K, Schultz S, Powell C, et al: Diaspirin cross-linked hemoglobin (DCLHb™): Control of pressor effect with anti-hypertensive agents. Biomaterials, Artificial Cells and Immobilization Biotechnology 1994; 22: 819-825